Nahirya-Ntege, PatriciaCook, AdrianOpilo, WilfredNamuddu, RachelKaturamu, RichardTezikyabbiri, JessicaNaidoo-James, BethanyGibb, Diana2023-02-222023-02-222012Nahirya-Ntege, P., Cook, A., Vhembo, T., Opilo, W., Namuddu, R., Katuramu, R., ... & ARROW Trial Team. (2012). Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa. PLoS One, 7(5), e36186.https://doi.org/10.1371/journal.pone.0036186https://nru.uncst.go.ug/handle/123456789/7939Provision of anti-retroviral therapy (ART) for HIV-infected children is complicated using syrup formulations, which are costlier than tablets, harder to transport and store and difficult for health-workers to prescribe and caregivers to administer. Dispersible/crushable tablets may be more appropriate. We studied the acceptability of syrups and scored tablets among young children who used both in the AntiRetroviral Research fOr Watoto (ARROW) trial.enHIVChildrenAdult CaregiversTabletsSyrup Antiretroviral MedicationsArticle